These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 9049232)

  • 21. Evaluation of oxidant stress in Wilson's disease and non-Wilsonian chronic liver disease in childhood.
    Dalgiç B; Sönmez N; Biberoğlu G; Hasanoğlu A; Erbaş D
    Turk J Gastroenterol; 2005 Mar; 16(1):7-11. PubMed ID: 16252181
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of hepatitis B].
    Telegdy L
    Orv Hetil; 2004 Nov; 145(45):2293-6. PubMed ID: 15573894
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of transferrin receptor 2 in hepatic accumulation of iron in patients with chronic hepatitis C.
    Mifuji R; Kobayashi Y; Ma N; Qiang QL; Urawa N; Horiike S; Iwasa M; Kaito M; Malavasi F; Adachi Y
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):144-51. PubMed ID: 16706826
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Therapeutic challenges in viral hepatitis patients].
    Bergk A; Berg T
    Dtsch Med Wochenschr; 2005 Dec; 130 Suppl 5():S218-20. PubMed ID: 16435715
    [No Abstract]   [Full Text] [Related]  

  • 25. The status of serum iron and transferrin saturation in acute non-hepatotrophic viral infections.
    Brill S; Weinberg M; Graff E; Moshkowitz M; Oren R
    J Med; 2000; 31(5-6):271-7. PubMed ID: 11508320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vitamins B depletion, lower iron status and decreased antioxidative defense in patients with chronic hepatitis C treated by pegylated interferon alfa and ribavirin.
    Lin CC; Yin MC
    Clin Nutr; 2009 Feb; 28(1):34-8. PubMed ID: 19042060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Interferon treatment of chronic hepatitis C viral hepatitis patients with normal transaminases].
    Remy AJ; Blanc P
    Gastroenterol Clin Biol; 1998; 22(8-9):748-9. PubMed ID: 9823572
    [No Abstract]   [Full Text] [Related]  

  • 28. [Progress in the treatment of chronic active liver diseases].
    Buligescu L; Spanache S
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1986; 38(5):413-27. PubMed ID: 2434980
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of iron depletion on serum markers of fibrogenesis, oxidative stress and serum liver enzymes in chronic hepatitis C: results of a pilot study.
    Alexander J; Tung BY; Croghan A; Kowdley KV
    Liver Int; 2007 Mar; 27(2):268-73. PubMed ID: 17311623
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Complete response to IFN in a case of typical HBV cirrhosis].
    Delmastro B; Mastinu A
    Minerva Med; 1997 Oct; 88(10):415-8. PubMed ID: 9417537
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of pretransplant and posttransplant viral cirrhosis].
    Suárez FJ; Otero A; Gómez M; Souto J; Vázquez-Iglesias JL
    Gastroenterol Hepatol; 2001 Feb; 24 Suppl 1():58-63. PubMed ID: 11279895
    [No Abstract]   [Full Text] [Related]  

  • 32. Review article: predicting response in hepatitis C virus therapy.
    Mihm U; Herrmann E; Sarrazin C; Zeuzem S
    Aliment Pharmacol Ther; 2006 Apr; 23(8):1043-54. PubMed ID: 16611264
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Current treatment of chronic hepatitis B].
    Rodríguez M; Pérez R
    Gastroenterol Hepatol; 2001 Feb; 24 Suppl 1():51-7. PubMed ID: 11279894
    [No Abstract]   [Full Text] [Related]  

  • 34. [Liver hemosiderosis in chronic hepatitis].
    Smirnov OA; Anichkov NM; Radchenko VG
    Arkh Patol; 2003; 65(1):39-42. PubMed ID: 12669612
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Iron reduction before and during interferon therapy of chronic hepatitis C: results of a multicenter, randomized, controlled trial.
    Fontana RJ; Israel J; LeClair P; Banner BF; Tortorelli K; Grace N; Levine RA; Fiarman G; Thiim M; Tavill AS; Bonkovsky HL
    Hepatology; 2000 Mar; 31(3):730-6. PubMed ID: 10706565
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatic oxidative DNA damage correlates with iron overload in chronic hepatitis C patients.
    Fujita N; Horiike S; Sugimoto R; Tanaka H; Iwasa M; Kobayashi Y; Hasegawa K; Ma N; Kawanishi S; Adachi Y; Kaito M
    Free Radic Biol Med; 2007 Feb; 42(3):353-62. PubMed ID: 17210448
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Antiviral effect of carnitine for chronic hepatitis or liver cirrhosis patients].
    Nakanishi H; Kurosaki M; Izumi N
    Nihon Rinsho; 2015 Dec; 73 Suppl 9():121-3. PubMed ID: 26845915
    [No Abstract]   [Full Text] [Related]  

  • 38. Interferons in the management of viral hepatitis.
    Zein NN
    Cytokines Cell Mol Ther; 1998 Dec; 4(4):229-41. PubMed ID: 10068057
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of chronic hepatitis C virus infection: we must target the virus or liver fibrosis?
    Soriano V; Martín-Carbonero L; García-Samaniego J
    AIDS; 2003 Mar; 17(5):751-3. PubMed ID: 12646800
    [No Abstract]   [Full Text] [Related]  

  • 40. Therapy of hepatitis C: other options.
    Bonkovsky HL
    Hepatology; 1997 Sep; 26(3 Suppl 1):143S-151S. PubMed ID: 9305680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.